Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients

Relapsed/refractory primary central nervous system lymphoma (PCNSL) and secondary central nervous system lymphoma (SCNSL) are associated with short survival and represent an unmet need, requiring novel effective strategies. Anti-CD19 chimeric antigen receptor (CAR) T cells, effective in systemic lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Michael R., Dorris, C. Scott, Makambi, Kepher H., Luo, Yutong, Munshi, Pashna N., Donato, Michelle, Rowley, Scott, Saad, Ayman, Goy, Andre, Dunleavy, Kieron, Ali, Alaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813524/
https://www.ncbi.nlm.nih.gov/pubmed/36260735
http://dx.doi.org/10.1182/bloodadvances.2022008525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813524/
https://www.ncbi.nlm.nih.gov/pubmed/36260735
http://dx.doi.org/10.1182/bloodadvances.2022008525

Ejemplares similares